Biomaterials in the treatment of Parkinson's disease

This review summarizes the major role played by biomaterials in design of novel strategies and in the improvement of existing therapeutic methods as well as the emerging trends in this domain

Uma Maheswari Krishnan

2021

Scholarcy highlights

  • Parkinson's disease is a neurodegenerative disease, the treatment of which is mainly centred around supplementation of dopamine
  • A wide range of biomaterials ranging from biomolecules, polymers, inorganic metal and metal oxide nanoparticles have been employed to assist the delivery of these therapeutic agents into the brain
  • Neuroprosthetics is an area that may become significant in treatment of motor deficits associated with Parkinson's disease, and involves development of highly conductive and robust electrode materials with excellent cytocompatibility
  • This review summarizes the major role played by biomaterials in design of novel strategies and in the improvement of existing therapeutic methods as well as the emerging trends in this domain

Need more features? Save interactive summary cards to your Scholarcy Library.